Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

Europe Nutrigenomics Market


Europe Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity

Report code: SDMRHE1640996 | Industry: Healthcare and Social Assistance | Published On: 44742


Europe nutrigenomics market was valued at $187.2 million in 2021 and will grow by 14.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes.
Highlighted with 35 tables and 59 figures, this 122-page report “Europe Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Country.

Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Products
o Probiotics
o Prebiotics
o Vitamins & Supplements
• Testing Services
o Nutrigenomics Clinical Testing
o Nutrigenomics Research Testing

Based on Test Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Next-generation Sequencing
• Real-time PCR
• DNA Microarray
• Sanger Sequencing

By Test Sample, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Buccal Swab Sample
• Saliva Sample
• Blood Sample
• Other Samples

By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Women’s Health
• Metabolic Disorders
• Immune Health
• Cancer Research
• Cardiovascular Diseases
• Diabetes
• Other Applications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Nutrition Clinics
• Diagnostics Laboratories
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Netherlands
• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering,Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction 7
1.1  Industry  Definition  and  Research  Scope 7
1.1.1  Industry  Definition 7
1.1.2  Research  Scope 8
1.2  Research  Methodology 11
1.2.1  Overview  of  Market  Research  Methodology 11
1.2.2  Market  Assumption 12
1.2.3  Secondary  Data 12
1.2.4  Primary  Data 12
1.2.5  Data  Filtration  and  Model  Design 13
1.2.6  Market  Size/Share  Estimation 14
1.2.7  Research  Limitations 15
1.3  Executive  Summary 16
2  Market  Overview  and  Dynamics 19
2.1  Market  Size  and  Forecast 19
2.1.1  Impact  of  COVID-19  on  World  Economy 20
2.1.2  Impact  of  COVID-19  on  the  Market 24
2.2  Major  Growth  Drivers 26
2.3  Market  Restraints  and  Challenges 34
2.4  Emerging  Opportunities  and  Market  Trends 37
2.5  Porter’s  Fiver  Forces  Analysis 41
3  Segmentation  of  Europe  Market  by  Offering 45
3.1  Market  Overview  by  Offering 45
3.2  Products 47
3.3.1  Probiotics 48
3.3.2  Prebiotics 49
3.3.3  Vitamins  &  Supplements 50
3.3  Testing  Services 51
3.3.1  Nutrigenomics  Clinical  Testing 52
3.3.2  Nutrigenomics  Research  Testing 53
4  Segmentation  of  Europe  Market  by  Test  Technology 54
4.1  Market  Overview  by  Test  Technology 54
4.2  Next-generation  Sequencing 56
4.3  Real-time  PCR 57
4.4  DNA  Microarray 58
4.5  Sanger  Sequencing 59
5  Segmentation  of  Europe  Market  by  Test  Sample 60
5.1  Market  Overview  by  Test  Sample 60
5.2  Buccal  Swab  Sample 62
5.3  Saliva  Sample 63
5.4  Blood  Sample 64
5.5  Other  Samples 65
6  Segmentation  of  Europe  Market  by  Application 66
6.1  Market  Overview  by  Application 66
6.2  Women’s  Health 68
6.3  Metabolic  Disorders 69
6.4  Immune  Health 70
6.5  Cancer  Research 71
6.6  Cardiovascular  Diseases 72
6.7  Diabetes 73
6.8  Other  Applications 74
7  Segmentation  of  Europe  Market  by  End  User 75
7.1  Market  Overview  by  End  User 75
7.2  Hospitals 77
7.3  Nutrition  Clinics 78
7.4  Diagnostics  Laboratories 79
7.5  Other  End  Users 80
8  European  Market  2021-2031  by  Country 81
8.1  Overview  of  European  Market 81
8.2  Germany 84
8.3  U.K. 86
8.4  France 88
8.5  Spain 90
8.6  Italy 92
8.7  Netherlands 94
8.8  Rest  of  European  Market 96
9  Competitive  Landscape 98
9.1  Overview  of  Key  Vendors 98
9.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 101
9.3  Company  Profiles 102
BASF  SE 102
BioGaia 104
Cell  Logic 105
Cura  Integrative  Medicine 106
DNAfit 107
DuPont  de  Nemours,  Inc. 108
Garden  of  Life,  LLC 109
GeneOmbio 110
Genova  Diagnostics,  Inc. 111
GX  Sciences,  Inc. 112
Ingredion  Incorporated 113
Jarrow  Formulas  Inc. 114
Koninklijke  DSM  N.V. 115
MedGenome 116
Metagenics,  Inc. 117
Nutrigenomix  Inc. 118
Unilever  Group 119
XCODE  Life 120
Yakult  Honsha  Co.,  Ltd. 121
RELATED  REPORTS 122
List of Tables:

Table 1. Snapshot of Europe Nutrigenomics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 33
Table 5. Main Product Trends and Market Opportunities in Europe Nutrigenomics Market 37
Table 6. Europe Nutrigenomics Market by Offering, 2021-2031, $ mn 45
Table 7. Europe Nutrigenomics Market: Products by Type, 2021-2031, $ mn 47
Table 8. Europe Nutrigenomics Market: Testing Services by Type, 2021-2031, $ mn 51
Table 9. Europe Nutrigenomics Market by Test Technology, 2021-2031, $ mn 54
Table 10. Europe Nutrigenomics Market by Test Sample, 2021-2031, $ mn 60
Table 11. Europe Nutrigenomics Market by Application, 2021-2031, $ mn 66
Table 12. Europe Nutrigenomics Market by End User, 2021-2031, $ mn 75
Table 13. Europe Nutrigenomics Market by Country, 2021-2031, $ mn 83
Table 14. Germany Nutrigenomics Market by Offering, 2021-2031, $ mn 85
Table 15. Germany Nutrigenomics Market by Application, 2021-2031, $ mn 85
Table 16. Germany Nutrigenomics Market by End User, 2021-2031, $ mn 85
Table 17. U.K. Nutrigenomics Market by Offering, 2021-2031, $ mn 87
Table 18. U.K. Nutrigenomics Market by Application, 2021-2031, $ mn 87
Table 19. U.K. Nutrigenomics Market by End User, 2021-2031, $ mn 87
Table 20. France Nutrigenomics Market by Offering, 2021-2031, $ mn 89
Table 21. France Nutrigenomics Market by Application, 2021-2031, $ mn 89
Table 22. France Nutrigenomics Market by End User, 2021-2031, $ mn 89
Table 23. Spain Nutrigenomics Market by Offering, 2021-2031, $ mn 91
Table 24. Spain Nutrigenomics Market by Application, 2021-2031, $ mn 91
Table 25. Spain Nutrigenomics Market by End User, 2021-2031, $ mn 91
Table 26. Italy Nutrigenomics Market by Offering, 2021-2031, $ mn 93
Table 27. Italy Nutrigenomics Market by Application, 2021-2031, $ mn 93
Table 28. Italy Nutrigenomics Market by End User, 2021-2031, $ mn 93
Table 29. Netherlands Nutrigenomics Market by Offering, 2021-2031, $ mn 95
Table 30. Netherlands Nutrigenomics Market by Application, 2021-2031, $ mn 95
Table 31. Netherlands Nutrigenomics Market by End User, 2021-2031, $ mn 95
Table 32. Nutrigenomics Market in Rest of Europe by Country, 2021-2031, $ mn 97
Table 33. BASF SE: Company Snapshot 102
Table 34. BASF SE: Business Segmentation 103
Table 35. BASF SE: Product Portfolio 103
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT